TScan Therapeutics gets Nasdaq notice over $1 minimum bid
Nasdaq notified the company that its common stock failed the $1.00 minimum bid price requirement under Listing Rule 5450(a)(1) for 30 consecutive trading days. Trading continues on Nasdaq Global Market; 180 days to Feb.
On August 27, 2026, the company received notice from Nasdaq that its common stock failed to meet the $1.00 minimum bid price requirement under Listing Rule 5450(a)(1) for 30 consecutive trading days.
Trading continues on the Nasdaq Global Market under TCRX, and the company has 180 days until Februa…